HitGen works with Scripps and Calibr | May 1, 2017 Issue - Vol. 95 Issue 18 | Chemical & Engineering News
Volume 95 Issue 18 | p. 17 | Concentrates
Issue Date: May 1, 2017 | Web Date: June 27, 2017

HitGen works with Scripps and Calibr

Department: Business
Keywords: drug discovery, Scripps, China, Pfizer

HitGen, a biotech company based in China with labs in Houston, will work with Scripps Research Institute and its affiliate, the California Institute for Biomedical Research (Calibr). The partners will use HitGen’s DNA-encoded small-molecule libraries to discover and develop oncology, regenerative medicine, and virology drugs. Scripps and Calibr will provide target materials and expertise. The alliance comes just one week after HitGen entered a multiyear drug discovery deal with Pfizer

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment